1. Home
  2. SNX vs RGEN Comparison

SNX vs RGEN Comparison

Compare SNX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TD SYNNEX Corporation

SNX

TD SYNNEX Corporation

HOLD

Current Price

$153.43

Market Cap

12.6B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.25

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNX
RGEN
Founded
1980
1981
Country
United States
United States
Employees
28500
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
8.2B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
SNX
RGEN
Price
$153.43
$162.25
Analyst Decision
Strong Buy
Buy
Analyst Count
10
10
Target Price
$168.60
$174.90
AVG Volume (30 Days)
742.3K
701.7K
Earning Date
01-08-2026
10-28-2025
Dividend Yield
1.14%
N/A
EPS Growth
18.98
N/A
EPS
9.21
0.03
Revenue
$60,973,509,000.00
$707,890,000.00
Revenue This Year
$7.25
$17.84
Revenue Next Year
$4.50
$12.57
P/E Ratio
$16.74
$5,259.20
Revenue Growth
6.94
11.74
52 Week Low
$92.23
$102.97
52 Week High
$167.76
$182.52

Technical Indicators

Market Signals
Indicator
SNX
RGEN
Relative Strength Index (RSI) 52.10 54.15
Support Level $147.58 $156.01
Resistance Level $158.68 $165.02
Average True Range (ATR) 3.35 4.65
MACD -0.20 -1.07
Stochastic Oscillator 52.66 43.33

Price Performance

Historical Comparison
SNX
RGEN

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: